

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.33612717 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.12331256 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.12331256 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01212781 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.01212781 |
| 6 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.00205374 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84437962 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.42964479 |
| 9 | cellular response to virus (GO:0098586) | 4.40922143 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.23515937 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.15908109 |
| 12 | activated T cell proliferation (GO:0050798) | 4.13468437 |
| 13 | detection of bacterium (GO:0016045) | 4.03198726 |
| 14 | response to type I interferon (GO:0034340) | 3.81620059 |
| 15 | cellular response to type I interferon (GO:0071357) | 3.72387335 |
| 16 | type I interferon signaling pathway (GO:0060337) | 3.72387335 |
| 17 | regulation of integrin activation (GO:0033623) | 3.68633034 |
| 18 | positive regulation of interferon-beta production (GO:0032728) | 3.58624390 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55276171 |
| 20 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.49396139 |
| 21 | diacylglycerol metabolic process (GO:0046339) | 3.47151226 |
| 22 | cellular response to zinc ion (GO:0071294) | 3.46464656 |
| 23 | proline biosynthetic process (GO:0006561) | 3.38871392 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 3.37077334 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.36191041 |
| 26 | regulation of regulatory T cell differentiation (GO:0045589) | 3.32882624 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.31123833 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30719944 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29461606 |
| 30 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27210839 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.24534885 |
| 32 | intestinal cholesterol absorption (GO:0030299) | 3.22982890 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22808585 |
| 34 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.20876080 |
| 35 | positive regulation of protein homooligomerization (GO:0032464) | 3.20549966 |
| 36 | regulation of protein glycosylation (GO:0060049) | 3.19951280 |
| 37 | positive thymic T cell selection (GO:0045059) | 3.17593938 |
| 38 | embryonic process involved in female pregnancy (GO:0060136) | 3.17429276 |
| 39 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.15572499 |
| 40 | cellular extravasation (GO:0045123) | 3.15095480 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.12828467 |
| 42 | regulation of tolerance induction (GO:0002643) | 3.11067732 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.10491726 |
| 44 | regulation of antigen processing and presentation (GO:0002577) | 3.08446303 |
| 45 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07305462 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.03513553 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.03513553 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.03513553 |
| 49 | positive regulation by symbiont of host defense response (GO:0052509) | 3.03513553 |
| 50 | modulation by symbiont of host defense response (GO:0052031) | 3.03513553 |
| 51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.03513553 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.03458153 |
| 53 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.03323521 |
| 54 | granulocyte activation (GO:0036230) | 3.02999071 |
| 55 | response to interferon-beta (GO:0035456) | 2.99921935 |
| 56 | response to interleukin-15 (GO:0070672) | 2.96663805 |
| 57 | positive regulation of B cell differentiation (GO:0045579) | 2.95532227 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 2.95045496 |
| 59 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.91517588 |
| 60 | regulation of interferon-beta production (GO:0032648) | 2.91193129 |
| 61 | negative thymic T cell selection (GO:0045060) | 2.90416164 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90268725 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.90211828 |
| 64 | detection of biotic stimulus (GO:0009595) | 2.90018734 |
| 65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89823081 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89296516 |
| 67 | negative regulation of phagocytosis (GO:0050765) | 2.86943062 |
| 68 | negative T cell selection (GO:0043383) | 2.83376138 |
| 69 | germinal center formation (GO:0002467) | 2.81581263 |
| 70 | T cell selection (GO:0045058) | 2.81102405 |
| 71 | negative regulation of innate immune response (GO:0045824) | 2.80745700 |
| 72 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80351983 |
| 73 | regulation of B cell differentiation (GO:0045577) | 2.78713280 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 2.78582658 |
| 75 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.78166872 |
| 76 | phospholipid efflux (GO:0033700) | 2.77770854 |
| 77 | tolerance induction (GO:0002507) | 2.76044485 |
| 78 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.75777114 |
| 79 | intestinal absorption (GO:0050892) | 2.75448487 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 2.75208042 |
| 81 | heterotypic cell-cell adhesion (GO:0034113) | 2.71751259 |
| 82 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71060852 |
| 83 | dendritic cell chemotaxis (GO:0002407) | 2.70998834 |
| 84 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.68929795 |
| 85 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.68929795 |
| 86 | mannose metabolic process (GO:0006013) | 2.67189446 |
| 87 | neutrophil chemotaxis (GO:0030593) | 2.66807925 |
| 88 | thymic T cell selection (GO:0045061) | 2.65563640 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 2.65418270 |
| 90 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.64917850 |
| 91 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64361988 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.63513660 |
| 93 | B cell mediated immunity (GO:0019724) | 2.63448630 |
| 94 | respiratory burst (GO:0045730) | 2.63219480 |
| 95 | response to peptidoglycan (GO:0032494) | 2.62908127 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 2.62897850 |
| 97 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62805217 |
| 98 | defense response to protozoan (GO:0042832) | 2.62600570 |
| 99 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61477374 |
| 100 | negative regulation of type I interferon production (GO:0032480) | 2.60811645 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 2.60528454 |
| 102 | neutrophil migration (GO:1990266) | 2.60041127 |
| 103 | regulation of cellular extravasation (GO:0002691) | 2.59878956 |
| 104 | cellular response to interleukin-15 (GO:0071350) | 2.59763532 |
| 105 | negative regulation of interleukin-8 production (GO:0032717) | 2.58952033 |
| 106 | leukocyte aggregation (GO:0070486) | 2.58207878 |
| 107 | cellular response to interferon-beta (GO:0035458) | 2.57590974 |
| 108 | proline metabolic process (GO:0006560) | 2.57407887 |
| 109 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57329705 |
| 110 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.56741297 |
| 111 | negative regulation of viral genome replication (GO:0045071) | 2.56365246 |
| 112 | regulation of RIG-I signaling pathway (GO:0039535) | 2.56229061 |
| 113 | regulation of defense response to virus by host (GO:0050691) | 2.56120043 |
| 114 | positive regulation of tolerance induction (GO:0002645) | 2.55027637 |
| 115 | negative regulation of viral entry into host cell (GO:0046597) | 2.54738641 |
| 116 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.54573025 |
| 117 | hepatocyte apoptotic process (GO:0097284) | 2.53573606 |
| 118 | leukocyte cell-cell adhesion (GO:0007159) | 2.52249749 |
| 119 | positive regulation of protein oligomerization (GO:0032461) | 2.51839268 |
| 120 | mature B cell differentiation involved in immune response (GO:0002313) | 2.49306598 |
| 121 | T-helper 1 type immune response (GO:0042088) | 2.49082738 |
| 122 | programmed necrotic cell death (GO:0097300) | 2.48413402 |
| 123 | protein-lipid complex assembly (GO:0065005) | 2.48372856 |
| 124 | regulation of protein homooligomerization (GO:0032462) | 2.47457623 |
| 125 | T cell migration (GO:0072678) | 2.46629880 |
| 126 | positive regulation of lamellipodium assembly (GO:0010592) | 2.44170254 |
| 127 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.43460499 |
| 128 | response to protozoan (GO:0001562) | 2.42674085 |
| 129 | mature B cell differentiation (GO:0002335) | 2.42643279 |
| 130 | response to interferon-alpha (GO:0035455) | 2.42543108 |
| 131 | cellular response to interferon-gamma (GO:0071346) | 2.41559667 |
| 132 | nucleotide salvage (GO:0043173) | 2.39576381 |
| 133 | regulation of cholesterol homeostasis (GO:2000188) | 2.38605545 |
| 134 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.36328189 |
| 135 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.35709305 |
| 136 | cytokine biosynthetic process (GO:0042089) | 2.34751283 |
| 137 | neutrophil activation (GO:0042119) | 2.34182205 |
| 138 | regulation of podosome assembly (GO:0071801) | 2.33973264 |
| 139 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.33118017 |
| 140 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32741318 |
| 141 | cholesterol efflux (GO:0033344) | 2.32080311 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.32042034 |
| 143 | DNA deamination (GO:0045006) | 2.31591361 |
| 144 | response to fungus (GO:0009620) | 2.30050261 |
| 145 | myeloid dendritic cell activation (GO:0001773) | 2.29439328 |
| 146 | flavonoid metabolic process (GO:0009812) | 2.29242054 |
| 147 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.28789292 |
| 148 | cellular response to dsRNA (GO:0071359) | 2.28469460 |
| 149 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.28459500 |
| 150 | alkaloid metabolic process (GO:0009820) | 2.27188450 |
| 151 | myeloid dendritic cell differentiation (GO:0043011) | 2.25620380 |
| 152 | detection of other organism (GO:0098543) | 2.24877643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.92822798 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.69794986 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21331680 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.99377141 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73301902 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61236545 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60776586 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50184562 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50061907 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49839704 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.47264068 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46989908 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.43799259 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40584505 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34065778 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33703812 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33477298 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07580196 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05425971 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99672588 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95278622 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87570591 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.86618508 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.86443342 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86429988 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86276775 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85455816 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83787928 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82167831 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78569498 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76392303 |
| 32 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75025071 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72852365 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.71784591 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66367364 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65257149 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63543845 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63366074 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62109195 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59580284 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58774929 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.58512171 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58323549 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58237418 |
| 45 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.57507758 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.56822660 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.56803866 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56737798 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.53914073 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49691911 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49632118 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46622270 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45924993 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45861584 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45820255 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42967182 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39624669 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37499370 |
| 59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36450272 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33927629 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33679898 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.32862193 |
| 63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.30919087 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27687087 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25960282 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.24506963 |
| 67 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23808455 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22907916 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22832596 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22012097 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20973791 |
| 72 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.20536256 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19225289 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.18534326 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18030107 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16938603 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16310635 |
| 78 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14642706 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14406407 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13800158 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13593006 |
| 82 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13586759 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12910872 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12813729 |
| 85 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11947205 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11887181 |
| 87 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11705740 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11136544 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11004512 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10867936 |
| 91 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10055889 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10003257 |
| 93 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09951437 |
| 94 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07352872 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06176189 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05877551 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05039609 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04713461 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03683108 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03268739 |
| 101 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02580021 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01285631 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99938117 |
| 104 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99647686 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98219880 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97434064 |
| 107 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97297665 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96821077 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96681368 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96557599 |
| 111 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94634094 |
| 112 | P300_27268052_Chip-Seq_Bcells_Human | 0.94590469 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94104102 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92337913 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92041934 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91681961 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91599868 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90003868 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.89181119 |
| 120 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88289435 |
| 121 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.87692321 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87646388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.34119079 |
| 2 | MP0000685_abnormal_immune_system | 3.07038766 |
| 3 | MP0005360_urolithiasis | 3.06063020 |
| 4 | MP0009785_altered_susceptibility_to | 2.72881573 |
| 5 | MP0003436_decreased_susceptibility_to | 2.71438157 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.51593312 |
| 7 | MP0005025_abnormal_response_to | 2.40672536 |
| 8 | MP0009840_abnormal_foam_cell | 2.31152947 |
| 9 | MP0008260_abnormal_autophagy | 2.29489891 |
| 10 | MP0006082_CNS_inflammation | 2.24823546 |
| 11 | MP0005671_abnormal_response_to | 2.21113840 |
| 12 | MP0001790_abnormal_immune_system | 2.18571660 |
| 13 | MP0005387_immune_system_phenotype | 2.18571660 |
| 14 | MP0001800_abnormal_humoral_immune | 2.17813493 |
| 15 | MP0001873_stomach_inflammation | 2.16082431 |
| 16 | MP0002419_abnormal_innate_immunity | 2.14893982 |
| 17 | MP0009278_abnormal_bone_marrow | 2.14639250 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.14156723 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.12999191 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.11501757 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.09957828 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.06645329 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.05845593 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.03517460 |
| 25 | MP0003724_increased_susceptibility_to | 2.01151035 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.00992839 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.96070120 |
| 28 | MP0002723_abnormal_immune_serum | 1.95823615 |
| 29 | MP0001851_eye_inflammation | 1.92583890 |
| 30 | MP0005365_abnormal_bile_salt | 1.92044979 |
| 31 | MP0001819_abnormal_immune_cell | 1.85015025 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.84306507 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.84306507 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.83734456 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.83348414 |
| 36 | MP0002405_respiratory_system_inflammati | 1.82791216 |
| 37 | MP0003303_peritoneal_inflammation | 1.81897298 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.74104165 |
| 39 | MP0004947_skin_inflammation | 1.64945137 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63999903 |
| 41 | MP0002006_tumorigenesis | 1.63269358 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.60891656 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.58992604 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.57460917 |
| 45 | MP0002398_abnormal_bone_marrow | 1.55241500 |
| 46 | MP0003866_abnormal_defecation | 1.55214420 |
| 47 | MP0000490_abnormal_crypts_of | 1.53299988 |
| 48 | MP0000716_abnormal_immune_system | 1.52885058 |
| 49 | MP0008469_abnormal_protein_level | 1.50621573 |
| 50 | MP0001853_heart_inflammation | 1.49225421 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.47589506 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.47050679 |
| 53 | MP0003252_abnormal_bile_duct | 1.44020632 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.40961477 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.36817401 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.32565428 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.31866224 |
| 58 | MP0002429_abnormal_blood_cell | 1.31512779 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.31386202 |
| 60 | MP0002722_abnormal_immune_system | 1.31206992 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.29358494 |
| 62 | MP0000609_abnormal_liver_physiology | 1.25519674 |
| 63 | MP0010329_abnormal_lipoprotein_level | 1.24795464 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.24663438 |
| 65 | MP0005451_abnormal_body_composition | 1.18607670 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.11935601 |
| 67 | MP0009764_decreased_sensitivity_to | 1.11399682 |
| 68 | MP0003075_altered_response_to | 1.10913113 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.10205527 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.08669714 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.07723390 |
| 72 | MP0008057_abnormal_DNA_replication | 1.06803487 |
| 73 | MP0002254_reproductive_system_inflammat | 1.06690635 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.06610889 |
| 75 | MP0005023_abnormal_wound_healing | 1.06594435 |
| 76 | MP0004510_myositis | 1.02135229 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.01704936 |
| 78 | MP0000343_altered_response_to | 1.01561200 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.98099573 |
| 80 | MP0003690_abnormal_glial_cell | 0.98087132 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.97251868 |
| 82 | MP0005310_abnormal_salivary_gland | 0.96857665 |
| 83 | MP0001663_abnormal_digestive_system | 0.95940941 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.95507968 |
| 85 | MP0002132_abnormal_respiratory_system | 0.91706474 |
| 86 | MP0003448_altered_tumor_morphology | 0.91469882 |
| 87 | MP0000477_abnormal_intestine_morphology | 0.90666065 |
| 88 | MP0005166_decreased_susceptibility_to | 0.89949443 |
| 89 | MP0000858_altered_metastatic_potential | 0.88496121 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.86935708 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.85815545 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.85328043 |
| 93 | MP0010307_abnormal_tumor_latency | 0.83944721 |
| 94 | MP0009763_increased_sensitivity_to | 0.83437525 |
| 95 | MP0000598_abnormal_liver_morphology | 0.82915675 |
| 96 | MP0001764_abnormal_homeostasis | 0.82907653 |
| 97 | MP0003795_abnormal_bone_structure | 0.82534884 |
| 98 | MP0005390_skeleton_phenotype | 0.82200084 |
| 99 | MP0000604_amyloidosis | 0.81496700 |
| 100 | MP0002933_joint_inflammation | 0.81161286 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.80508535 |
| 102 | MP0000371_diluted_coat_color | 0.80377336 |
| 103 | MP0000249_abnormal_blood_vessel | 0.79388397 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.78333838 |
| 105 | MP0003045_fibrosis | 0.77213854 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.76462207 |
| 107 | MP0002019_abnormal_tumor_incidence | 0.76299078 |
| 108 | MP0003828_pulmonary_edema | 0.75843745 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75111695 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.73989824 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.73373752 |
| 112 | MP0008004_abnormal_stomach_pH | 0.71813848 |
| 113 | MP0003329_amyloid_beta_deposits | 0.70373298 |
| 114 | MP0005164_abnormal_response_to | 0.70341782 |
| 115 | MP0005165_increased_susceptibility_to | 0.69742607 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.67006739 |
| 117 | MP0004381_abnormal_hair_follicle | 0.66569659 |
| 118 | MP0004883_abnormal_blood_vessel | 0.65804010 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.60966565 |
| 120 | MP0003195_calcinosis | 0.59985441 |
| 121 | MP0009115_abnormal_fat_cell | 0.57333888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 5.05946945 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.54208233 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.49031569 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.16703107 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84176147 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 3.76476792 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.72588985 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71397605 |
| 9 | Polycythemia (HP:0001901) | 3.68700922 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.35940890 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.34944591 |
| 12 | Myositis (HP:0100614) | 3.18497910 |
| 13 | Colitis (HP:0002583) | 3.08656513 |
| 14 | Mucopolysacchariduria (HP:0008155) | 3.03819825 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03819825 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.03721066 |
| 17 | Increased IgM level (HP:0003496) | 3.03612501 |
| 18 | Chronic otitis media (HP:0000389) | 2.95824323 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.95479868 |
| 20 | Recurrent skin infections (HP:0001581) | 2.94719154 |
| 21 | Recurrent viral infections (HP:0004429) | 2.94580259 |
| 22 | Abnormality of T cell number (HP:0011839) | 2.89587962 |
| 23 | Encephalitis (HP:0002383) | 2.89345347 |
| 24 | Pulmonary infiltrates (HP:0002113) | 2.79728834 |
| 25 | Inflammation of the large intestine (HP:0002037) | 2.78777635 |
| 26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.76317731 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.76317731 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.76317731 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 2.75666700 |
| 30 | Thrombocytosis (HP:0001894) | 2.74290893 |
| 31 | Abnormality of T cell physiology (HP:0011840) | 2.72527227 |
| 32 | Myocardial infarction (HP:0001658) | 2.71248408 |
| 33 | Pulmonary embolism (HP:0002204) | 2.68923583 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.68650763 |
| 35 | Cheilitis (HP:0100825) | 2.68043182 |
| 36 | Gingivitis (HP:0000230) | 2.67590509 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.67522688 |
| 38 | Hypochromic anemia (HP:0001931) | 2.67472531 |
| 39 | Malnutrition (HP:0004395) | 2.63300928 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 2.62653187 |
| 41 | Poikiloderma (HP:0001029) | 2.61112770 |
| 42 | Nasal polyposis (HP:0100582) | 2.60745882 |
| 43 | Tongue fasciculations (HP:0001308) | 2.60514410 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.58852615 |
| 45 | Alopecia of scalp (HP:0002293) | 2.54080610 |
| 46 | Periodontitis (HP:0000704) | 2.52206389 |
| 47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.49761732 |
| 48 | Gingival bleeding (HP:0000225) | 2.49441280 |
| 49 | Petechiae (HP:0000967) | 2.46575957 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 2.45283941 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.43316882 |
| 52 | Orchitis (HP:0100796) | 2.42986359 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.41066023 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.40961346 |
| 55 | Intrahepatic cholestasis (HP:0001406) | 2.38734504 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.38389059 |
| 57 | Chest pain (HP:0100749) | 2.37658302 |
| 58 | Increased serum ferritin (HP:0003281) | 2.37275926 |
| 59 | Amyloidosis (HP:0011034) | 2.37076463 |
| 60 | Complement deficiency (HP:0004431) | 2.36363649 |
| 61 | Purpura (HP:0000979) | 2.35830937 |
| 62 | Abnormality of T cells (HP:0002843) | 2.35315358 |
| 63 | Epistaxis (HP:0000421) | 2.35007172 |
| 64 | Albinism (HP:0001022) | 2.33700305 |
| 65 | Vasculitis (HP:0002633) | 2.32450476 |
| 66 | IgM deficiency (HP:0002850) | 2.32254475 |
| 67 | Increased IgE level (HP:0003212) | 2.32096298 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 2.31972913 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.30837377 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30603017 |
| 71 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30603017 |
| 72 | Abnormal platelet volume (HP:0011876) | 2.30270107 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.30180193 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29227281 |
| 75 | Glomerulonephritis (HP:0000099) | 2.28683669 |
| 76 | Muscle fibrillation (HP:0010546) | 2.28537224 |
| 77 | Joint hemorrhage (HP:0005261) | 2.25745821 |
| 78 | Gastrointestinal dysmotility (HP:0002579) | 2.24997681 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.23554984 |
| 80 | Abnormality of complement system (HP:0005339) | 2.22948897 |
| 81 | Obstructive lung disease (HP:0006536) | 2.22122276 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22122276 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.21009408 |
| 84 | Chronic diarrhea (HP:0002028) | 2.20335133 |
| 85 | Polygenic inheritance (HP:0010982) | 2.20101019 |
| 86 | Restrictive lung disease (HP:0002091) | 2.18300759 |
| 87 | Keratoconjunctivitis (HP:0001096) | 2.17892248 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16666407 |
| 89 | T lymphocytopenia (HP:0005403) | 2.13060701 |
| 90 | Meningitis (HP:0001287) | 2.12866254 |
| 91 | Nephritis (HP:0000123) | 2.12806793 |
| 92 | IgA deficiency (HP:0002720) | 2.11835399 |
| 93 | Facial hemangioma (HP:0000329) | 2.11256498 |
| 94 | Increased mean platelet volume (HP:0011877) | 2.09969955 |
| 95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08855719 |
| 96 | Cupped ribs (HP:0000887) | 2.08542496 |
| 97 | Esophageal varix (HP:0002040) | 2.08489592 |
| 98 | Cellulitis (HP:0100658) | 2.07212294 |
| 99 | Xanthomatosis (HP:0000991) | 2.05459323 |
| 100 | Abnormal platelet function (HP:0011869) | 2.05269434 |
| 101 | Impaired platelet aggregation (HP:0003540) | 2.05269434 |
| 102 | Leukocytosis (HP:0001974) | 2.02006429 |
| 103 | Metaphyseal cupping (HP:0003021) | 2.01870316 |
| 104 | Urticaria (HP:0001025) | 2.00999157 |
| 105 | Anorexia (HP:0002039) | 2.00696915 |
| 106 | Bronchitis (HP:0012387) | 2.00536417 |
| 107 | Gangrene (HP:0100758) | 2.00004191 |
| 108 | Premature loss of primary teeth (HP:0006323) | 1.99242124 |
| 109 | Microcytic anemia (HP:0001935) | 1.99141222 |
| 110 | Fat malabsorption (HP:0002630) | 1.98554420 |
| 111 | Lymphopenia (HP:0001888) | 1.98085177 |
| 112 | Prolonged bleeding time (HP:0003010) | 1.97884400 |
| 113 | Stomatitis (HP:0010280) | 1.97616697 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.96979709 |
| 115 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96542434 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96542434 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96542434 |
| 118 | Autoimmune hemolytic anemia (HP:0001890) | 1.95988291 |
| 119 | Deep venous thrombosis (HP:0002625) | 1.95094990 |
| 120 | Combined immunodeficiency (HP:0005387) | 1.94602664 |
| 121 | Increased cerebral lipofuscin (HP:0011813) | 1.94521928 |
| 122 | Emphysema (HP:0002097) | 1.94166663 |
| 123 | Thrombophlebitis (HP:0004418) | 1.93705619 |
| 124 | Arterial thrombosis (HP:0004420) | 1.92970616 |
| 125 | Hypertriglyceridemia (HP:0002155) | 1.92488664 |
| 126 | Sparse scalp hair (HP:0002209) | 1.91897192 |
| 127 | Abnormality of the pleura (HP:0002103) | 1.91521858 |
| 128 | Osteomyelitis (HP:0002754) | 1.91431705 |
| 129 | Eosinophilia (HP:0001880) | 1.91241660 |
| 130 | Retrobulbar optic neuritis (HP:0100654) | 1.89482306 |
| 131 | Optic neuritis (HP:0100653) | 1.89482306 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89291084 |
| 133 | Severe combined immunodeficiency (HP:0004430) | 1.88285594 |
| 134 | Hemoptysis (HP:0002105) | 1.87449883 |
| 135 | Ureteral stenosis (HP:0000071) | 1.87001155 |
| 136 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86150437 |
| 137 | Granulocytopenia (HP:0001913) | 1.85932518 |
| 138 | Skin ulcer (HP:0200042) | 1.84831719 |
| 139 | Gastrointestinal infarctions (HP:0005244) | 1.82574010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 4.32358313 |
| 2 | MAP4K1 | 3.21656973 |
| 3 | IKBKE | 3.06489639 |
| 4 | TYK2 | 2.80201586 |
| 5 | PIM2 | 2.60188381 |
| 6 | BLK | 2.51210310 |
| 7 | PRKCH | 2.35365513 |
| 8 | MAP3K14 | 2.32616547 |
| 9 | ERN1 | 2.30133524 |
| 10 | CSK | 2.29813179 |
| 11 | PRPF4B | 2.17198538 |
| 12 | MAP3K11 | 2.08556623 |
| 13 | KIT | 1.99988988 |
| 14 | IKBKB | 1.98610317 |
| 15 | GRK6 | 1.89964547 |
| 16 | MATK | 1.89771604 |
| 17 | JAK3 | 1.88829674 |
| 18 | MAPK15 | 1.79655005 |
| 19 | IRAK4 | 1.73373178 |
| 20 | ICK | 1.70429944 |
| 21 | MAP3K6 | 1.67435773 |
| 22 | ZAP70 | 1.66431528 |
| 23 | TNK2 | 1.60565134 |
| 24 | FGR | 1.58708098 |
| 25 | TXK | 1.56558628 |
| 26 | EPHA3 | 1.52704986 |
| 27 | MST4 | 1.52538513 |
| 28 | FGFR4 | 1.51806116 |
| 29 | PIM1 | 1.51036306 |
| 30 | FLT3 | 1.47156230 |
| 31 | STK10 | 1.42042278 |
| 32 | PBK | 1.41963974 |
| 33 | DDR2 | 1.41795020 |
| 34 | CSF1R | 1.39393352 |
| 35 | JAK1 | 1.38951900 |
| 36 | MAP2K3 | 1.37806638 |
| 37 | MAP3K1 | 1.36091824 |
| 38 | TGFBR2 | 1.33471755 |
| 39 | BTK | 1.32110651 |
| 40 | TAOK3 | 1.30554846 |
| 41 | MAP3K13 | 1.28988501 |
| 42 | MAP3K10 | 1.25096246 |
| 43 | RIPK4 | 1.20040595 |
| 44 | MAPK11 | 1.15417669 |
| 45 | KDR | 1.14924791 |
| 46 | IRAK3 | 1.12314408 |
| 47 | TEC | 1.11869191 |
| 48 | BMX | 1.11753457 |
| 49 | EPHB1 | 1.08436601 |
| 50 | SMG1 | 1.05922036 |
| 51 | LCK | 1.03725864 |
| 52 | LYN | 1.00841791 |
| 53 | TRPM7 | 1.00337375 |
| 54 | SYK | 0.97525665 |
| 55 | DYRK1B | 0.95540753 |
| 56 | NME2 | 0.93782527 |
| 57 | TAOK1 | 0.92268177 |
| 58 | JAK2 | 0.92259809 |
| 59 | RIPK1 | 0.91115402 |
| 60 | PKN2 | 0.90352280 |
| 61 | PTK6 | 0.90297359 |
| 62 | TRIB3 | 0.88888326 |
| 63 | CDK6 | 0.88488989 |
| 64 | CHUK | 0.87801901 |
| 65 | CDC42BPA | 0.87241134 |
| 66 | IRAK1 | 0.85391595 |
| 67 | HIPK2 | 0.85047870 |
| 68 | PRKG2 | 0.84716825 |
| 69 | RPS6KA6 | 0.83590585 |
| 70 | LRRK2 | 0.82693518 |
| 71 | HCK | 0.82209692 |
| 72 | RPS6KL1 | 0.81941797 |
| 73 | RPS6KC1 | 0.81941797 |
| 74 | DAPK1 | 0.80039140 |
| 75 | YES1 | 0.79813494 |
| 76 | TGFBR1 | 0.76315513 |
| 77 | MST1R | 0.76111815 |
| 78 | ITK | 0.74184126 |
| 79 | TYRO3 | 0.72780053 |
| 80 | SIK3 | 0.71690808 |
| 81 | MAP3K3 | 0.70122036 |
| 82 | PRKCQ | 0.69889162 |
| 83 | PRKD2 | 0.66470366 |
| 84 | TAOK2 | 0.65163557 |
| 85 | EPHA2 | 0.64291647 |
| 86 | RPS6KA2 | 0.63928183 |
| 87 | PAK4 | 0.63816937 |
| 88 | MAP3K8 | 0.63556629 |
| 89 | ARAF | 0.63200698 |
| 90 | MARK2 | 0.62248682 |
| 91 | CDK7 | 0.61926508 |
| 92 | MAP3K2 | 0.57543496 |
| 93 | KSR2 | 0.57479528 |
| 94 | MAP3K7 | 0.56347610 |
| 95 | MAPK4 | 0.55936712 |
| 96 | RET | 0.54043361 |
| 97 | FES | 0.53719683 |
| 98 | PDPK1 | 0.52046460 |
| 99 | MAPKAPK2 | 0.50332115 |
| 100 | PRKAA2 | 0.49847329 |
| 101 | TESK2 | 0.49082373 |
| 102 | MAPK7 | 0.48905904 |
| 103 | FYN | 0.48463363 |
| 104 | PDK1 | 0.48112289 |
| 105 | GRK7 | 0.47877760 |
| 106 | TESK1 | 0.47853684 |
| 107 | BCKDK | 0.46512492 |
| 108 | PRKCD | 0.46050691 |
| 109 | EGFR | 0.45827229 |
| 110 | ABL1 | 0.44716250 |
| 111 | RPS6KA4 | 0.44492188 |
| 112 | RAF1 | 0.44077819 |
| 113 | FGFR3 | 0.42333888 |
| 114 | SIK1 | 0.40440221 |
| 115 | MAPK12 | 0.39414472 |
| 116 | TTN | 0.38061599 |
| 117 | RPS6KA1 | 0.37889863 |
| 118 | EEF2K | 0.37341730 |
| 119 | GSK3A | 0.37245416 |
| 120 | MAPK3 | 0.36546419 |
| 121 | NEK9 | 0.36055950 |
| 122 | MARK3 | 0.35540814 |
| 123 | RPS6KB2 | 0.35503981 |
| 124 | STK38 | 0.35235643 |
| 125 | MAP2K2 | 0.34838442 |
| 126 | MAP2K6 | 0.34463747 |
| 127 | SIK2 | 0.34194356 |
| 128 | NLK | 0.32750410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.18136446 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.79713703 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63155482 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45295629 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.30393617 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.27248531 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21101593 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10256512 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98027769 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.91175205 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86351793 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.83985039 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81143438 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.80112366 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.79657231 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72899386 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.70360876 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.68176875 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67277929 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56811084 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54318524 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48620008 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47733784 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42708661 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39356479 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39153738 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38231037 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33920767 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33442727 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31275852 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.31033849 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.28679773 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.27274296 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23420570 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23093611 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22357424 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.16884717 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16604277 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13872928 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.13047117 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.12900305 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12898975 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12608439 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12300217 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11848794 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10631989 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.10516273 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.10067070 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08814492 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07958458 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06196824 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.04829787 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.04741744 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04045217 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.03917223 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03244524 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 1.02521921 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01891226 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01806416 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 1.00175119 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99520092 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.98890283 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.97642443 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96361788 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93775004 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93142015 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93108414 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91388518 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.87667581 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86594867 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86515078 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86403139 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86164900 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.85934893 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83717762 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82603171 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81910047 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.80349373 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80255301 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79676412 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79237339 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78285590 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77809626 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77460700 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.76305604 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75856707 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74102748 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72384195 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69107429 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68788018 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68200860 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65180524 |
| 93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63836241 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63520267 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.62521801 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.62043070 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62015972 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60380366 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.60117053 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59731151 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59644717 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54824569 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54033218 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53811141 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53193052 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.53123489 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51514146 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50862237 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49490892 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48778747 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48773881 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48674931 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.48363220 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48018499 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47084437 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46791693 |
| 117 | Asthma_Homo sapiens_hsa05310 | 0.45729148 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45058289 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44958327 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44140106 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43790845 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43566405 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43216532 |
| 124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42640836 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38930979 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38324901 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38235876 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35835865 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35199983 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.34790712 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34281038 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29542256 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27520721 |

